(Q49012285)

17 February 2018

title

MGMT promoter gene methylation in pediatric glioblastoma: analysis using MS-MLPA. (English)

1 reference

17 February 2018

1 reference

Ji Yeoun Lee

1

1 reference

17 February 2018

Chul-Kee Park

2

1 reference

17 February 2018

Sung-Hye Park

3

1 reference

17 February 2018

Kyu-Chang Wang

4

1 reference

17 February 2018

Byung-Kyu Cho

5

1 reference

17 February 2018

Seung-Ki Kim

6

1 reference

17 February 2018

publication date

26 July 2011

1 reference

17 February 2018

published in

Child's Nervous System

1 reference

17 February 2018

volume

27

1 reference

17 February 2018

issue

11

1 reference

17 February 2018

page(s)

1877-1883

1 reference

17 February 2018

https://scigraph.springernature.com/pub.10.1007/s00381-011-1525-7

exact match

0 references

cites work

Current therapeutic paradigms in glioblastoma

1 reference

https://api.crossref.org/works/10.1007%2FS00381-011-1525-7

O6-methylguanine-DNA methyltransferase expression strongly correlates with outcome in childhood malignant gliomas: results from the CCG-945 Cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00381-011-1525-7

Treatment of infants with malignant gliomas: the Pediatric Oncology Group experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00381-011-1525-7

Long-term survival in patients with glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00381-011-1525-7

Resection, biopsy, and survival in malignant glial neoplasms. A retrospective study of clinical parameters, therapy, and outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00381-011-1525-7

Pediatric glioblastomas: a histopathological and molecular genetic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00381-011-1525-7

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00381-011-1525-7

MGMT gene silencing and benefit from temozolomide in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00381-011-1525-7

MGMT promoter methylation is predictive of response to radiotherapy and prognostic in the absence of adjuvant alkylating chemotherapy for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00381-011-1525-7

MS-MLPA: an attractive alternative laboratory assay for robust, reliable, and semiquantitative detection of MGMT promoter hypermethylation in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00381-011-1525-7

Methylation-specific MLPA (MS-MLPA): simultaneous detection of CpG methylation and copy number changes of up to 40 sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00381-011-1525-7

MGMT promoter methylation correlates with survival benefit and sensitivity to temozolomide in pediatric glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00381-011-1525-7

Evaluation status and prognostic significance of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation in pediatric high grade gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00381-011-1525-7

MGMT gene promoter methylation in pediatric glioblastomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00381-011-1525-7

Long-term outcomes in children with glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00381-011-1525-7

Methylation of O6-methylguanine DNA methyltransferase and loss of heterozygosity on 19q and/or 17p are overlapping features of secondary glioblastomas with prolonged survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00381-011-1525-7

Usefulness of MS-MLPA for detection of MGMT promoter methylation in the evaluation of pseudoprogression in glioblastoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00381-011-1525-7

Temozolomide in malignant gliomas of childhood: a United Kingdom Children's Cancer Study Group and French Society for Pediatric Oncology Intergroup Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00381-011-1525-7

Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors: a report from the Children's Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00381-011-1525-7

Phase II trial of temozolomide in children with recurrent high-grade glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00381-011-1525-7

Role of temozolomide in pediatric brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00381-011-1525-7

Mismatch repair deficiency is an uncommon mechanism of alkylator resistance in pediatric malignant gliomas: a report from the Children's Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00381-011-1525-7

MGMT analysis at DNA, RNA and protein levels in glioblastoma tissue

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21789683

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Quantification of the methylation status of the PWS/AS imprinted region: comparison of two approaches based on bisulfite sequencing and methylation-sensitive MLPA

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21789683

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Prognostic value of O6-methylguanine-DNA methyltransferase status in glioblastoma patients, assessed by five different methods

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21789683

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00381-011-1525-7

1 reference

17 February 2018

Dimensions Publication ID

1012291028

0 references

1 reference

17 February 2018